CD44 and neoplasm: Such results may support the hypothesis that FAK inhibition induced by reducing CD147-binding molecules (such as CD44 and integrins) following anti-CD147 antibody treatment promotes cytoskeletal stress-dependent activation of JNK and SMAD4, leading to tumor cell death with caspase-3 activation.